IgE-Mediated Food Allergies: New Therapies to Prevent Allergic Reactions and Improve Management

Overview

Provider Statement

This continuing education activity is jointly provided by and 

Support Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Activity Description

Food allergies are serious and potentially life-threatening conditions affecting more than 33 million Americans, with up to 8% of children and 10% of adults impacted. Approximately 1 in 13 children has a food allergy, equating to nearly 2 children in every US classroom. Alarmingly, one-third of these children report being bullied due to their condition. Food allergies can lead to severe reactions, sending a patient to the emergency room every 10 seconds. This continuing medical education program, titled "IgE-Mediated Food Allergies: New Therapies to Prevent Allergic Reactions and Improve Management," aims to equip healthcare providers with the latest knowledge and skills to enhance patient outcomes. Immunoglobulin E (IgE)-mediated food allergies are particularly dangerous, often leading to anaphylaxis, respiratory distress, and cardiac arrest. While traditionally considered a pediatric disease, food allergies increasingly affect adults. The 9 most common food allergens in the United States are milk, egg, peanut, tree nuts, soy, wheat, fish, shellfish, and sesame. With the advent of new therapies such as immunotherapy and biologic agents, there are now more options for managing IgE-mediated food allergies. This program will delve into these innovative treatments, with an emphasis on their safety and efficacy. Additionally, the tethered course will highlight some of the key findings from a recent social media program for patients, as well as address the significant racial and ethnic disparities in food allergy prevalence and outcomes—promoting strategies for shared decision-making to enhance patient care.

Target Audience

The intended audience for this activity is allergists, pediatricians, family medicine physicians, physician associates, nurse practitioners, and other healthcare professionals involved in the management of patients with food allergies.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Describe the pathophysiology and burden of immunoglobulin (Ig)E-mediated food allergy reactions.
• Outline the safety and efficacy of current and emerging therapies to treat IgE-mediated food allergies in adult and pediatric patients.
• Recognize racial and ethnic disparities in the prevalence of food allergies and effect on food allergy outcomes.
• Identify shared decision-making strategies for improved outcomes in patients with IgE-mediated food allergies.

Activity Chair

Kelly Cleary, MD, FAAP
Senior Director of Education and Support Programs
Food Allergy Research and Education (FARE)
Westfield, NJ

Faculty

R. Sharon Chinthrajah, MD, FAAAAI
Associate Professor
Allergy, Immunology, Pulmonary and Critical Care
Co-Director
Sean N Parker Center for Allergy and Asthma Research
Stanford University
Stanford, CA

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Vindico Medical Education and Food Allergy & Research Education. Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, June 21, 2024, to June 20, 2025.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

R. Sharon Chinthrajah, MD, FAAAAI
Advisor: Alladapt, Genentech, IgGenix, Intrommune, Novartis

Kelly Cleary, MD, FAAP
No relevant financial relationships to disclose.

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education Staff

No relevant financial relationships to disclose.

Food Allergy Research & Education Staff

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education and Food Allergy Research & Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education or Food Allergy Research & Education. Neither Vindico Medical Education, Food Allergy Research & Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:

• Specify the copyrighted work you believe has been infringed upon.
• Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
• Share your name, address, telephone number, and, if available, your email address.
• Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
• Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
• Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614

CE Questions?

Contact us at cme@vindicoCME.com